Skip to search.
 TSX Up 0.47% TSX Ventures Up 1.46%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
5.61 Down 0.26(4.43%) Apr 29, 4:00PM EDT
|After Hours : 5.61 0.00 (0.00%) Apr 29, 4:35PM EDT
Prev Close:5.87
Open:5.84
Bid:5.55 x 1000
Ask:6.75 x 100
1y Target Est:11.25
Beta:0.135132
Next Earnings Date:N/A
Day's Range:5.56 - 6.00
52wk Range:3.55 - 23.67
Volume:68,846
Avg Vol (3m):231,325
Market Cap:193.28M
P/E (ttm):133.57
EPS (ttm):0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OSIRDown 4.43%193.28M
UCBJYDown 1.64%14.46B
BIIBDown 2.17%60.24B
ABTDown 3.76%57.31B

Key Statistics

Forward P/E (1 yr):43.15
P/S (ttm):2.34
Ex-Dividend Date:14-Oct-15

Analysts

Annual EPS Est (Dec-15) :0.08
Quarterly EPS Est (Dec-15) :0.06
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback